Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Cash Flows from Operating Activities:
Net Income	$ 15,430,383	$ 13,396,769	$ 10,256,362
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,544,470	3,817,205	2,421,177
Abandoned patents or software written off	413,589	250,523	66,619
Provision for bad debts	2,475,032	1,806,299	1,544,521
Deferred income tax benefit - net	$ (2,756,517)	$ (2,682,405)	(2,473,892)
Gain on Sale of Equipment			$ (557,473)
Loss on disposition of equipment		$ 657,350
Gain on litigation settlement			$ (755,500)
Impairment on management agreement			357,500
Compensatory element of stock issuances	$ 53,200	$ 223,000	$ 415,021
Gain on extinguishment of debt	(394,797)
Stock issued for costs and expenses	$ 109,950	$ 531,825
Stock option exercised		30,600
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivables	$ (4,258,147)	$ (4,044,002)	$ (3,717,440)
Notes receivable	135,592	95,623	120,976
Costs and estimated earnings in excess of Billings on uncompleted contracts	78,149	(314,067)	682,854
Inventories	251,687	(366,448)	117,861
Prepaid expenses and other current assets	67,192	46,967	(698,284)
Other assets	41,125	131,811	(204,037)
Increase (decrease) in operating liabilities, net:
Accounts payable	(699,555)	(270,482)	628,033
Other current liabilities	(1,041,214)	295,219	(414,402)
Customer advances	$ 11,000	$ 68,943	(567,914)
Billings in excess of costs and estimated earnings on uncompleted contracts			142,217
Other Liabilities	$ (190,561)	$ (268,261)	253,559
Due to related medical practices	$ 2,339	3,955	1,885
Income tax payable		(19,501)	(80,499)
NET CASH PROVIDED BY OPERATING ACTIVITIES	$ 13,272,917	13,390,923	7,539,144
Cash Flows from Investing Activities:
Purchases of property and equipment	$ (131,308)	$ (620,697)	(1,135,382)
Cost of acquisition			(40,000,000)
Cost of patents	$ (139,534)	$ (214,211)	(159,907)
NET CASH USED IN INVESTING ACTIVITIES	$ (270,842)	$ (834,908)	(41,295,289)
Cash Flows from Financing Activities:
Proceeds from debt			14,689,646
Proceeds from sale of equipment			700,000
Proceeds from noncontrolling interests			19,800,000
Repayment of borrowings and capital lease obligations	$ (2,788,401)	$ (4,400,128)	(1,821,617)
Repayment of notes receivable from employee stockholders	7,333	15,992	15,993
Distributions to noncontrolling interests	(4,627,851)	(4,965,770)	(1,799,950)
Redemption of noncontroling Interests	(1,125,000)	$ (1,125,100)	(1,424,900)
Buyout of noncontroling Interest	(4,971,094)		(564,315)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(13,505,013)	$ (10,475,006)	29,594,857
Net Increase in Cash and Cash Equivalents	(502,938)	2,081,009	(4,161,288)
Cash and Cash Equivalents - Beginning of Period	9,951,736	7,870,727	12,032,015
Cash and Cash Equivalents - End of Period	$ 9,448,798	$ 9,951,736	$ 7,870,727